Barclays CEO says his cancer was 'detected early', doctors 'very optimistic'

Published on November 29, 2022 04:17 PM GMT

http://rmb.reuters.com/rmd/rss/content/tag:reuters.com,2022:newsml_LYNXMPEIAS0S5:1/tag:reuters.com,2022:binary_LYNXMPEIAS0S5-BASEIMAGE

LONDON (Reuters) - The cancer affecting Barclays Chief Executive C.S. Venkatakrishnan was detected early and is "very localised", meaning doctors are optimistic, he told a conference on Tuesday.

Barclays said on Monday that Venkatakrishnan would undergo 12-16 weeks of treatment in New York for non-Hodkin lymphoma.

The bank has not appointed an interim replacement and Venkatakrishnan will stay involved with the running of the bank where treatment allows, a spokesperson for the bank said on Monday.

(Reporting By Lawrence White and Iain Withers; editing by David Evans)

Reuters

Reuters -
94290 Posts
...

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.